JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB216620

Anti-GLP2 antibody

4

(1 Review)

|

(1 Publication)

Rabbit Polyclonal GLP-1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human GCG aa 1-50 conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

Pro-glucagon, GCG, GCG, GLP 2, GRPP, Glucagon like peptide 2

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GLP2 antibody (AB216620)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GLP2 antibody (AB216620)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded human stomach tissue labeling GLP2 with ab216620 at 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human GCG aa 1-50 conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P01275

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.02% Proclin 300 Constituents: 50% Glycerol (glycerin, glycerine), 48.98% TBS, 1X, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glucagon-like peptide 2 (GLP2) also known as glucagon-like peptide-2 and GLP-2 is a peptide that is derived from the proglucagon gene and weighs approximately 4.2 kDa. It is expressed mostly in the intestinal mucosa particularly in the L-cells of the ileum and colon. GLP2 is a 33-amino-acid peptide hormone that is secreted in response to nutrient intake. This peptide is involved in various bodily functions acting mainly in the gastrointestinal tract.
Biological function summary

GLP2 functions to enhance intestinal growth and nutrient absorption. It promotes mucosal epithelial growth increases villus height and reduces gut permeability. These actions make GLP2 critical for maintaining the structural and functional integrity of the gastrointestinal tract. It operates independently and is not part of a larger protein complex but works alongside similar hormones for gut homeostasis.

Pathways

GLP2 is involved in the enteroendocrine signaling pathway. This includes the modulation of the GLP2 receptor which impacts intestinal growth and function. The peptide also shows interplay with proteins like glucagon-like peptide 1 (GLP1) as both affect energy balance and glucose homeostasis although through different mechanisms. GLP2's primary role in enhancing nutrient absorption complements GLP1's efforts in glucose regulation.

GLP2's link to short bowel syndrome and inflammatory bowel disease highlights its therapeutic potential. Its ability to improve intestinal adaptation and reduce inflammation positions GLP2 as a candidate for treating these conditions. Additionally a connection exists with glucagon-like peptide 1 (GLP1) due to their common origin and overlapping pathways although each has distinct functions and disease relevance.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Glucagon. Plays a key role in glucose metabolism and homeostasis. Regulates blood glucose by increasing gluconeogenesis and decreasing glycolysis. A counterregulatory hormone of insulin, raises plasma glucose levels in response to insulin-induced hypoglycemia. Plays an important role in initiating and maintaining hyperglycemic conditions in diabetes. Binds to and activates the glucagon receptor GCGR, which couples to the G(s) G protein and elevates intracellular cAMP, triggering downstream metabolic responses (PubMed : 32193322).. Glucagon-like peptide 1. Potent stimulator of glucose-dependent insulin release (PubMed : 22037645, PubMed : 40446798). Also stimulates insulin release in response to IL6 (PubMed : 22037645). Plays important roles on gastric motility and the suppression of plasma glucagon levels (PubMed : 10605628, PubMed : 14719035, PubMed : 12554744). May be involved in the suppression of satiety and stimulation of glucose disposal in peripheral tissues, independent of the actions of insulin (PubMed : 10605628, PubMed : 14719035, PubMed : 12554744). Has growth-promoting activities on intestinal epithelium (PubMed : 10605628, PubMed : 14719035, PubMed : 12554744). May also regulate the hypothalamic pituitary axis (HPA) via effects on LH, TSH, CRH, oxytocin, and vasopressin secretion (PubMed : 10605628, PubMed : 14719035, PubMed : 12554744). Increases islet mass through stimulation of islet neogenesis and pancreatic beta cell proliferation (PubMed : 10605628, PubMed : 14719035, PubMed : 12554744). Inhibits beta cell apoptosis (PubMed : 10605628, PubMed : 14719035, PubMed : 12554744).. Glucagon-like peptide 2. Stimulates intestinal growth and up-regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. The gastrointestinal tract, from the stomach to the colon is the principal target for GLP-2 action. Plays a key role in nutrient homeostasis, enhancing nutrient assimilation through enhanced gastrointestinal function, as well as increasing nutrient disposal. Stimulates intestinal glucose transport and decreases mucosal permeability.. Oxyntomodulin. Significantly reduces food intake. Inhibits gastric emptying in humans. Suppression of gastric emptying may lead to increased gastric distension, which may contribute to satiety by causing a sensation of fullness.. Glicentin. May modulate gastric acid secretion and the gastro-pyloro-duodenal activity. May play an important role in intestinal mucosal growth in the early period of life.
See full target information GCG

Additional targets

GLP2

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Physiological reports 11: PubMed37962017

2023

The effects of treadmill exercise on brain angiogenesis in ovariectomized rats.

Applications

Unspecified application

Species

Unspecified reactive species

Eun-Jung Yoon,Jiwon Jeong,Eunji Yoon,Dongsun Park
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com